Actively Recruiting
Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration
Led by Pharmicell Co., Ltd. · Updated on 2026-02-10
100
Participants Needed
1
Research Sites
552 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This Long-term follow-up is designed to evaluate the safety of patient with Acute Myocardial Infarction who had administered Hearticellgram-AMI.
CONDITIONS
Official Title
Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have been administered Hearticellgram-AMI
- Patients who voluntarily agree in writing to participate in this investigation
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
KIMHYUNSOO Clinic
Seoul, Gangnam, South Korea, 06017
Actively Recruiting
Research Team
D
DAEUN JUNG
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here